| Bioactivity | Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Complement factor D-IN-2 targets factor D and inhibits the complement cascade at an early and essential point in the alternative complement pathway. Complement factor D-IN-2 can be used for the research of autoimmune diseases[1]. |
| Target | complement factor D |
| Invitro | Complement factor D-IN-2 reduces the excessive activation of complement factor D[1]. |
| Name | Complement factor D-IN-2 |
| CAS | 1903742-34-6 |
| Formula | C27H24BrN7O3 |
| Molar Mass | 574.43 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. GADHACHANDA VR, et, al. Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders. WO2015130838A1. |
Complement factor D-IN-2
CAS: 1903742-34-6 F: C27H24BrN7O3 W: 574.43
Complement factor D-IN-2 is an inhibitor of complement factor D extracted from patent WO2015130838A1, compound 190. Comp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.